Billionaire Hedge Fund Owner Carl Icahn Buying at Least $184 million in Shares in FirstEnergy, Utility Says (Akron Beacon Journal)
FirstEnergy Corp.’s latest earnings report — it made more than $1.1 billion in profit last year — took a back seat Thursday morning to executives explaining how they are making the Akron utility more open and focused on compliance as it deals with federal and state investigations over the $61 million Householder bribery scandal. The utility also disclosed that billionaire investor and hedge fund manager Carl Icahn said in a Feb. 16 letter he and affiliates intend to buy significant shares in the company. Icahn told the utility he intends to buy more than $184 million in FirstEnergy shares.
Jeffrey Gundlach Says Bitcoin May Be a Better Bet Than Gold (Bloomberg)
DoubleLine Capital LP chief and long-time gold bull Jeffrey Gundlach has changed his mind on the metal and considers Bitcoin a better trade. Gundlach tweeted he’d been a long-term gold bull and U.S. dollar bear, but has turned neutral on both. Bitcoin may well be “the stimulus asset,” he said, a reference to the cryptocurrency’s rally amid a wave of cash pumped into the financial system during the pandemic.
Dan Loeb’s Third Point Adds New Stakes in Alphabet and Nike — Here are His Top Positions (CNBC)
Hedge fund manager Dan Loeb bought new stakes in Google-parent Alphabet and Nike during the fourth quarter, according to securities filings. Loeb’s Third Point fund reported its end of December holdings on Tuesday, showing eight long positions worth more than $400 million.
Thursday 2/18 Insider Buying Report: CRVS, SGFY (Nasdaq.com)
At Corvus Pharmaceuticals, a filing with the SEC revealed that on Wednesday, CEO Richard A. Miller, M.D. purchased 100,000 shares of CRVS, for a cost of $3.50 each, for a total investment of $350,000. So far Miller, M.D. is in the green, up about 7.1% on their buy based on today’s trading high of $3.75. Corvus Pharmaceuticals is trading up about 2.5% on the day Thursday. And on Tuesday, Director Vivian E. Riefberg bought $333,600 worth of Signify Health, buying 13,900 shares at a cost of $24.00 a piece. This purchase marks the first one filed by Riefberg in the past year. Signify Health is trading off about 1.4% on the day Thursday. So far Riefberg is in the green, up about 57.5% on their purchase based on today’s trading high of $37.81.
What Did This CEO Just Do with Personal Shares of Carnival (NYSE: CCL)? (Analyst Ratings)
Yesterday, the President & CEO of Carnival (CCL), Arnold Donald, sold shares of CCL for $897.9K. In addition to Arnold Donald, 13 other CCL executives reported Sell trades in the last month. Following Arnold Donald’s last CCL Sell transaction on January 19, 2021, the stock climbed by 2.3%.
Zebra Technologies Corp (ZBRA) CEO Anders Gustafsson Sold $7.6 million of Shares (Guru Focus)
CEO of Zebra Technologies Corp, Anders Gustafsson, sold 15,865 shares of ZBRA on 02/16/2021 at an average price of $479.39 a share. The total sale was $7.6 million. Zebra Technologies Corp develops products for the automatic identification and data capture market. Its products find use in mobiles, computers, barcode scanners, RFID readers, specialty printers. Zebra Technologies Corp has a market cap of $25.5 billion; its shares were traded at around $476.990000 with a P/E ratio of 50.97 and P/S ratio of 5.77. Zebra Technologies Corp had annual average EBITDA growth of 20.20% over the past ten years.
